Prevalence of generalized anxiety disorder in COVID-19 patients admitted in a tertiary care hospital in South India: A cross-sectional study

Authors

  • Lakshmi KP Amrita Institute of Medical sciences and Research Center
  • Subhash Chandra Amrita Institute of Medical Sciences and Research Center
  • Kudrat Jain Amrita Institute of Medical Sciences and Research Center
  • Bindu Menon Amrita Institute of Medical Sciences and Research Center

DOI:

https://doi.org/10.30834/KJP.35.1.2022.321

Abstract

Background: SARS-CoV-2 virus can affect the lungs and other organs of our body, including the brain. Studies from various parts of the world have started reporting a high prevalence of anxiety disorder in COVID-19 patients. This study aims to estimate the prevalence of generalized anxiety disorder in patients admitted with COVID-19 infection in a tertiary care medical college in South India. Methods: All COVID positive patients admitted to a tertiary care medical college during the study period were evaluated by a psychiatrist, and diagnosis was made based on ICD-10. GAD-7scale was used to assess the severity of anxiety disorder. Results: Hundred and eighty-four COVID-19 patients were studied. Generalized anxiety disorder was detected in 34.8% of the patients. Conclusions: Generalized anxiety disorder is highly prevalent in COVID-19 patients. Proper screening and treating generalized anxiety disorder in them will help in the care of these patients.

References

Duan L, Zhu G. Psychological interventions for people affected by the COVID-19 epidemic. Lancet Psychiatry. 2020 Apr;7(4):300-302.

Brooks SK, Webster RK, Smith LE, Woodland L,

Wessely S, Greenberg N, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020 Mar 14;395(10227):912-920. doi: 10.1016/S0140-6736(20)30460-8.

Islam MS, Ferdous MZ, Potenza MN. Panic and generalized anxiety during the COVID-19 pandemic among Bangladeshi people: An online pilot survey early in the outbreak. J Affect Disord. 2020 Nov 1;276:30-37.

Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7..

Kroenke K, Spitzer RL, Williams JB, Monahan PO, Löwe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007 Mar 6;146(5):317-25.

Taquet M, Luciano S, Geddes J R, Harrison P J. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62?354 COVID-19 cases in the USA. Lancet Psychiatry. 2021 Nov 9;8(2):130-140.

Pandey AK, Shukla A, Chaudhary N, Kumar N, Srivastava A K, Dubey P K. Estimating the Prevalence of Anxiety Disorder in COVID 19 Patients-A Cross Sectional Study. Journal of Research in Medical and Dental Sciences. 2020 Sep ;8(6):136-141.

Kumar P, Chaudhary R, Chhabra S, Bhalla JK. Prevalence of anxiety and depression among COVID-19 patients admitted to tertiary care hospital. Indian J Soc Psychiatry. 2021 Mar 31;37(1):88-92.

Cárdaba-García RM, Pérez Pérez L, Niño Martín V, Cárdaba-García I, Durantez-Fernández C, Olea E. Evaluation of the Risk of Anxiety and/or Depression during Confinement Due to COVID-19 in Central Spain. Int J Environ Res Public Health. 2021 May 27;18(11):5732.

Downloads

Published

2022-05-11

How to Cite

Lakshmi KP, Subhash Chandra, Kudrat Jain, & Bindu Menon. (2022). Prevalence of generalized anxiety disorder in COVID-19 patients admitted in a tertiary care hospital in South India: A cross-sectional study. Kerala Journal of Psychiatry, 35(1), 54–57. https://doi.org/10.30834/KJP.35.1.2022.321

Issue

Section

Research Report